These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pseudomonas aeruginosa genotypes acquired by children with cystic fibrosis by age 5-years. Kidd TJ; Ramsay KA; Vidmar S; Carlin JB; Bell SC; Wainwright CE; Grimwood K; J Cyst Fibros; 2015 May; 14(3):361-9. PubMed ID: 25563522 [TBL] [Abstract][Full Text] [Related]
7. The clinical significance of oropharyngeal cultures in young children with cystic fibrosis. Breuer O; Caudri D; Akesson L; Ranganathan S; Stick SM; Schultz A; Eur Respir J; 2018 May; 51(5):. PubMed ID: 29678944 [TBL] [Abstract][Full Text] [Related]
8. Costs of bronchoalveolar lavage-directed therapy in the first 5 years of life for children with cystic fibrosis. Moodie M; Lal A; Vidmar S; Armstrong DS; Byrnes CA; Carlin JB; Cheney J; Cooper PJ; Grimwood K; Robertson CF; Tiddens HA; Wainwright CE; J Pediatr; 2014 Sep; 165(3):564-569.e5. PubMed ID: 24996984 [TBL] [Abstract][Full Text] [Related]
9. Bronchoalveolar lavage-directed therapy in children with cystic fibrosis and Pseudomonas aeruginosa infection. Linnane B; McNally P JAMA; 2011 Oct; 306(16):1761; author reply 1761-2. PubMed ID: 22028348 [No Abstract] [Full Text] [Related]
10. Long-term outcomes of early exposure to repeated general anaesthesia in children with cystic fibrosis (CF-GAIN): a multicentre, open-label, randomised controlled phase 4 trial. Wainwright CE; Vidmar S; Anderson V; Bourgeat P; Byrnes C; Carlin JB; Cheney J; Cooper P; Davidson A; Gailer N; Grayson-Collins J; Quittner A; Robertson C; Salvado O; Zannino D; Armstrong FD; ; Lancet Respir Med; 2024 Sep; 12(9):703-713. PubMed ID: 38851197 [TBL] [Abstract][Full Text] [Related]
12. Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial. Saiman L; Anstead M; Mayer-Hamblett N; Lands LC; Kloster M; Hocevar-Trnka J; Goss CH; Rose LM; Burns JL; Marshall BC; Ratjen F; JAMA; 2010 May; 303(17):1707-15. PubMed ID: 20442386 [TBL] [Abstract][Full Text] [Related]
13. Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis. Armstrong DS; Grimwood K; Carlin JB; Carzino R; Olinsky A; Phelan PD Pediatr Pulmonol; 1996 May; 21(5):267-75. PubMed ID: 8726151 [TBL] [Abstract][Full Text] [Related]
15. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. Li Z; Kosorok MR; Farrell PM; Laxova A; West SE; Green CG; Collins J; Rock MJ; Splaingard ML JAMA; 2005 Feb; 293(5):581-8. PubMed ID: 15687313 [TBL] [Abstract][Full Text] [Related]
16. Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis. Douglas TA; Brennan S; Gard S; Berry L; Gangell C; Stick SM; Clements BS; Sly PD Eur Respir J; 2009 Feb; 33(2):305-11. PubMed ID: 19010992 [TBL] [Abstract][Full Text] [Related]
17. Cyanide in bronchoalveolar lavage is not diagnostic for Pseudomonas aeruginosa in children with cystic fibrosis. Stutz MD; Gangell CL; Berry LJ; Garratt LW; Sheil B; Sly PD; Eur Respir J; 2011 Mar; 37(3):553-8. PubMed ID: 20562125 [TBL] [Abstract][Full Text] [Related]
18. Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age. Byrnes CA; Vidmar S; Cheney JL; Carlin JB; Armstrong DS; Cooper PJ; Grimwood K; Moodie M; Robertson CF; Rosenfeld M; Tiddens HA; Wainwright CE; Thorax; 2013 Jul; 68(7):643-51. PubMed ID: 23345574 [TBL] [Abstract][Full Text] [Related]
19. Bronchiectases at early chest computed tomography in children with cystic fibrosis are associated with increased risk of subsequent pulmonary exacerbations and chronic pseudomonas infection. Bortoluzzi CF; Volpi S; D'Orazio C; Tiddens HA; Loeve M; Tridello G; Assael BM J Cyst Fibros; 2014 Sep; 13(5):564-71. PubMed ID: 24726420 [TBL] [Abstract][Full Text] [Related]